Group | Average years age | Gender | School Education Level |
||||
Incomplete Elementary | Complete Elementary | Incomplete high | Complete high | University Education | |||
Control | 48 | F = 17 M = 0 |
8 | 2 | 0 | 4 | 3 |
MDD | 53 | F = 15 M = 2 |
6 | 6 | 0 | 3 | 2 |
Citation: Amanda G Bertollo, Roberta E Grolli, Marcos E Plissari, Vanessa A Gasparin, João Quevedo, Gislaine Z Réus, Margarete D Bagatini, Zuleide M Ignácio. Stress and serum cortisol levels in major depressive disorder: a cross-sectional study[J]. AIMS Neuroscience, 2020, 7(4): 459-469. doi: 10.3934/Neuroscience.2020028
[1] | Ahlem Matallah, Rabie Guezi, Abdelmadjid Bairi . Repeated restraint stress induced neurobehavioral and sexual hormone disorders in male rats. AIMS Neuroscience, 2022, 9(2): 264-276. doi: 10.3934/Neuroscience.2022014 |
[2] | Shahzaib Maqbool, Arham Ihtesham, Muhammad Nadeem Langove, Sara Jamal, Tabdar Jamal, Hafiz Abu Safian . Neuro-dermatological association between psoriasis and depression: an immune-mediated inflammatory process validating skin-brain axis theory. AIMS Neuroscience, 2021, 8(3): 340-354. doi: 10.3934/Neuroscience.2021018 |
[3] | AB Segarra, I Prieto, M Martínez-Cañamero, Manuel Ramírez-Sánchez . Is there a link between depression, neurochemical asymmetry and cardiovascular function?. AIMS Neuroscience, 2020, 7(4): 360-372. doi: 10.3934/Neuroscience.2020022 |
[4] | Pranav Chintamani Joshi, Sugato Benerjee . Effects of glucocorticoids in depression: Role of astrocytes. AIMS Neuroscience, 2018, 5(3): 200-210. doi: 10.3934/Neuroscience.2018.3.200 |
[5] | Stefan G. Hofmann, Elizabeth A. Mundy, Joshua Curtiss . Neuroenhancement of Exposure Therapy in Anxiety Disorders. AIMS Neuroscience, 2015, 2(3): 123-138. doi: 10.3934/Neuroscience.2015.3.123 |
[6] | Akshay Reddy, Mohammad Reza Hosseini, Aashay Patel, Ramy Sharaf, Vishruth Reddy, Arman Tabarestani, Brandon Lucke-Wold . Deep brain stimulation, lesioning, focused ultrasound: update on utility. AIMS Neuroscience, 2023, 10(2): 87-108. doi: 10.3934/Neuroscience.2023007 |
[7] | Laaziz Abderrahim, El Mostafi Hicham, Elhessni Aboubaker, Azeroil Fatima, Touil Tarik, Boumlah Soufiane, Mesfioui Abdelhalim . Sex differences in behavioral, cognitive and voluntary ethanol-intake effects in Dexamethasone-induced depression-like state in Wistar rat. AIMS Neuroscience, 2022, 9(2): 228-249. doi: 10.3934/Neuroscience.2022012 |
[8] | I. B. Mosse, N. G. Sedlyar, K. A. Mosse, A. V. Kilchevsky . DNA methylation differences in genes associated with human personal disorders and deviant behavior. AIMS Neuroscience, 2024, 11(1): 39-48. doi: 10.3934/Neuroscience.2024003 |
[9] | Ashok Chakraborty, Anil Diwan . Depression and Parkinson's disease: a Chicken-Egg story. AIMS Neuroscience, 2022, 9(4): 479-490. doi: 10.3934/Neuroscience.2022027 |
[10] | Mani Pavuluri, Kelley Volpe, Alexander Yuen . Nucleus Accumbens and Its Role in Reward and Emotional Circuitry: A Potential Hot Mess in Substance Use and Emotional Disorders. AIMS Neuroscience, 2017, 4(1): 52-70. doi: 10.3934/Neuroscience.2017.1.52 |
According to the World Health Organization (WHO), major depressive disorder (MDD) in 2004 ranked first in ranking the leading causes of non-fatal disability and third place in the global burden of disability. The estimate is that MDD will occupy the first place in 2030, among the diseases with the highest global burden [1]. In addition to being a significant cause of disability, MDD affects more than 264 million people worldwide and is the leading cause of suicides [2].
Some psychosocial factors are involved in triggering depression. Stressful events in childhood, adolescence, or adulthood are considered villains due to their ability to trigger psychiatric disorders, such as depression or depressive-like behaviors in animals [3],[4]. The manifestations are variable both by the intensity and amount of stressful episodes and the particularity of each person and how they react to stressful events. Multiple child abuse during childhood, such as sexual and physical abuse, neglect, and violence in the family, are correlated with increased vulnerability to MDD in adult life [5]–[7]. In adulthood, personal losses, marital disagreements, or other chronic stressors can become triggers for MDD development [7],[8].
MDD is a complex disorder and presents a heterogeneity of pathophysiological mechanisms [9],[10]. Chronic stress throughout life involves several biological changes, which are underlying MDD in many patients and in laboratory animals [4],[6],[9]. Stressful events interacting with genetic mechanisms become strong allies in triggering anatomical and functional changes in MDD and other psychiatric disorders [11]. Among neurobiological mechanisms associated to stress and MDD are changes in dopaminergic, serotonergic, and noradrenergic neurotransmission systems [10],[12].
Among the most relevant biological phenomena involved in chronic stress throughout life and, consequently, in MDD is the change in the hypothalamic-pituitary-adrenal axis (HPA) function [13],[14]. Hypercortisolism is a relevant feature associated with melancholic-type depression [9].
Some research points to socioeconomic conditions as important denominators influencing the onset of psychiatric disorders [15]. Although MDD is present in individuals of various social situations, it seems to increase considerably in poor populations and low socioeconomic status, suggesting that this condition is a significant risk factor for the disorder [7],[16],[17].
In addition to socio-cultural factors, some research has indicated differences in the proportion of patients and severity of MDD between urban and rural communities, suggesting that some rural populations are highly prone to MDD [18]. Šidlauskaitė-Stripeikienė et al. [19] observed a rural community high rate of depression among adults, correlated with a low level of education, low social support, and social network, and high levels of stress. Although this study's protocol did not select a specific condition for this research in MDD patients, some characteristics of the population evaluated are the predominance of individuals in a rural community and low socioeconomic status. These conditions are substantial factors underlying chronic stress and vulnerability for MDD development.
Therefore, this study aimed to investigate stress and cortisol levels in a sample of individuals clinically diagnosed with MDD in the Basic Health Unit (BHU) of a small municipality in the western region of Santa Catarina, Brazil.
This is a cross-sectional study. After approval of the project by the local Ethics Committee (Protocol 183/12), 17 individuals with MDD treated at BHU and 17 control subjects, over 18 years of age, free of any pathology and without using medication for at least 30 days before the study, were selected. Both MDD and control subjects were invited to participate in the study voluntarily. All individuals received information about the research and its objectives, with free and informed consent, as specified in resolution 196/96 of the National Health Council, and freely participated in the study through consent term. Subjects with MDD, established through clinical and laboratory criteria, free of other pathologies that could compromise the research data were included in the research. Individuals who participated as controls in the study were also registered with the municipality's BHU but did not diagnose MDD. It is a small municipality, and in the period of the research, it had a population of around five thousand inhabitants [20]. The health unit organization in the city has all inhabitants registered to monitor the population's health. Subjects outside the established age range or who had other associated pathologies were excluded.
Individuals who agreed to participate in the survey were evaluated in the morning, at an appropriate location indicated by BHU. At the time of the interview and application of the questionnaires, blood was collected for the serum cortisol levels analyses.
To stress levels of the participants, this study used an inventory of stress symptoms. The inventory consisted of an adaptation, with items obtained from the Checklist-90-R [21]. The Checklist-90-R Symptom Inventory (SCL-90-R) is composed of 90 (ninety) items, of which 24 (twenty-four) were elected, with a score ranging from zero to five points in each item. Items that express stress symptoms were chosen, comparing them with stress items of the Lipp and Guevara (1994) Stress Symptoms Inventory [22]. The items identified are related to symptoms of anxiety, depression, hostilities, and somatization but are not attributed only to a psychiatric disorder. The SCL-90-R was chosen because it is practical, easy to apply, and used for psychological assessment in individuals with several pathologies and evaluated at the general clinic [23].
Beck's depression inventory [24] was utilized to investigate and confirm the clinical diagnoses of depressive disorders. The inventory constituted of 21 questions about feelings present in the last 30 days. Each item presented four possibilities (between 0 and 3 points) to answer. The research considered the sum of each response's value for the total score of the assessed population.
For analysis of serum cortisol levels was adopted the chemiluminescence method. The immunoenzymatic assay was performed using automatic chemiluminescence equipment, model Immulite 2000, described by [25],[26]. According to the manufacturer's recommendations, adjustments were made in four replicates when starting the routine chemiluminescence analysis on this device.
Inventory data and plasma cortisol levels were analyzed using the parametric t-test for independent groups. A parametric test was also adopted to investigate a possible correlation between stress and depression scores, as evidenced in MDD individuals. For the correlation test, Pearson's correlation coefficient “r” was observed. The level of significance admitted for all tests was p < 0.05. The data were analyzed using the software Statistica.
Some sociodemographic data of the MDD individuals and controls, such as gender, age, and education level, are shown in table 1.
Individuals clinically diagnosed with MDD at the HBS showed a significantly higher value in the sum of Beck's depression scores than the control subjects (Means ± EPM: Patients = 24.42 ± 2.86; Controls = 9.88 ± 1.65; p < 0.001) (Figure 1).
Group | Average years age | Gender | School Education Level |
||||
Incomplete Elementary | Complete Elementary | Incomplete high | Complete high | University Education | |||
Control | 48 | F = 17 M = 0 |
8 | 2 | 0 | 4 | 3 |
MDD | 53 | F = 15 M = 2 |
6 | 6 | 0 | 3 | 2 |
The analyses also evidenced a significant difference in the sum of the scores of the stress inventory, Checklist-90-R (Means ± SEM: Patients = 50.64 ± 5.37; Controls = 22.71 ± 3.70; p < 0.001) (Figure 2).
The statistical analysis also showed a significant correlation between the scores of the depression and the stress in individuals diagnosed with MDD in the clinic, with an index r = 0.70 (Figure 3). Although cortisol levels are significantly higher in MDD individuals, correlation analysis showed no significant correlation between depression scores and cortisol levels. There was also no significant correlation between stress scores and cortisol levels.
Regarding serum cortisol, MDD individuals had significantly higher levels than control subjects. Results are expressed as Means ± SEM of micrograms per deciliter of serum (mcg/dL) (Patients = 11.92 ± 1.02; Controls = 7.99 ± 0.83; p < 0.05). (Figure 4).
This study showed a significant difference between MDD individuals and control subjects through Beck's depression inventory scores, indicating that MDD had significantly higher depression scores than control subjects. These results reinforce the clinical diagnosis of MDD obtained by individuals at the HBU.
Regarding the stress levels measured through the items listed in the Checklist-90-R inventory, MDD also had significantly higher scores than the control subjects.
The Beck depression inventory is one of the most widely used scales worldwide and has high internal consistency and validity in differentiating between MDD individuals and controls [24]. In addition to numerous empirical studies that use the inventory over time, since its construction in 1961 [27], several recent studies continue to use the inventory in several research protocols. Some authors have observed that yoga practice resulted in lower depression scores through the Beck inventory [28]. Other studies have observed that the probiotic supplement can be a useful tool in controlling mild or moderate depressive disorder and emphasized the effectiveness of using the Beck inventory as an essential tool that can be used frequently in the clinic to assist in the diagnosis of MDD [29].
Similarly, Checklist-90-R, in addition to its relevance in stress measures, is used as a tool to assess depressive symptoms, as it covers stress measures closely related to MDD. A survey of anxious and depressed patients used the Checklist-90-R to evaluate cognitive-behavioral therapy's effect on these disorders. The results suggested a beneficial effect of the therapy, corroborating the scale's usefulness in assessing depressive and anxious symptoms [30].
Depression has a profound negative effect on people's lives and health and is related to high levels of stress generated by uncertainties and low resilience levels [31]. Chronic stress is a highly relevant factor in triggering and shares critical physiological changes in MDD. Exposure to life stressors is one of the most relevant precipitating factors in developing depressive episodes [32]. It is already well defined in the scientific literature that recurrent depression can be a consequence of exposure to chronic stress events during life [6]. In this study, in addition to a significant increase in stress scores, the results of MDD individuals showed a significantly positive correlation with depression levels, reinforcing the involvement of chronic stress in disorder.
Among the most critical physiological mechanisms affected by chronic stress is the function of the HPA axis [9]. Chronic stress has a relevant involvement in the deregulation of the axis action and the recurrence and severity of MDD [33].
Although changes in the HPA axis may differ according to the MDD subtype, scientific literature has shown that chronic stress can deregulate the axis feedback system, increase cortisol levels [34], and culminate in a situation of resistance to glucocorticoids [13].
It is crucial to highlight the results in a recent meta-analysis, which found that cortisol was the only biological marker that increased the odds for both the onset and relapse/recurrence of MDD [35].
Among other functions of glucocorticoids, there is the inhibition of the transcription of inflammatory molecules, thus controlling the exacerbation of inflammatory processes [36]–[38]. However, in situations of resistance to glucocorticoids, the pro-inflammatory response becomes excessive [39]. Chronic inflammation is involved in the vulnerability of the development of MDD and other psychiatric disorders. Glucocorticoid resistance is also a factor that potentiates the severity of MDD [37],[40],[41].
Stress, both in early life and adulthood, is highly related to inflammation, mainly if caused by a feeling of possible risk and physical or social threat, commonly reported by individuals with MDD [37],[42]. Many studies also provide evidence that inflammation, both peripheral and central, is strongly associated with MDD [43].
It is also important to consider studies with evidence that individuals with low socioeconomic status submitted to stress conditions have a peripheral increase in interleukin 6 (IL-6), a pro-inflammatory cytokine [44].
Thus, the evidence in this study suggests that stress is involved with hyperactivity of the HPA axis, with increased levels of cortisol, which is possibly a relevant mechanism mediating stress and MDD in these individuals.
A probable limitation of this study is related to the small number of individuals evaluated. However, depression scores through the inventory are clinically confirmed. Besides, the levels of stress and cortisol are indicators that strengthen the results of this research.
Individuals clinically diagnosed with MDD had higher scores for depression and stress-related symptoms. MDD individuals also had significantly higher levels of cortisol than control subjects. Also, depression scores were positively correlated with stress scores. These results suggest that chronic stress is involved in elevated cortisol levels, which, at least in part, appears to be the underlying mechanism of MDD in these individuals.
[1] | World Health Organization The Global Burden of Disease: 2004, 2008. Available from: https://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/. |
[2] | World Health Organization Depression: Fact sheet. World Health Organization, 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/depression. |
[3] |
Chapman DP, Whitfield CL, Felitti VJ, et al. (2004) Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord 82: 217-225. doi: 10.1016/j.jad.2003.12.013
![]() |
[4] |
Ignácio ZM, Réus GZ, Abelaira HM, et al. (2017) Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation. Behav Brain Res 320: 225-232. doi: 10.1016/j.bbr.2016.11.044
![]() |
[5] |
Vranceanu AM, Hobfoll SE, Johnson RJ (2007) Child multi-type maltreatment and associated depression and PTSD symptoms: The role of social support and stress. Child Abuse Negl 31: 71-84. doi: 10.1016/j.chiabu.2006.04.010
![]() |
[6] |
Ignácio ZM, Réus GZ, Abelaira HM, et al. (2014) Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression. Neuroscience 275: 455-468. doi: 10.1016/j.neuroscience.2014.06.036
![]() |
[7] |
Hasin DS, Sarvet AL, Meyers JL, et al. (2018) Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. JAMA Psychiatry 75: 336-346. doi: 10.1001/jamapsychiatry.2017.4602
![]() |
[8] |
Constance H (2005) Stress and Depression. Rev Clin Psychol 1: 293-319. doi: 10.1146/annurev.clinpsy.1.102803.143938
![]() |
[9] | Gold PW, Machado-Vieira R, Pavlatou MG (2015) Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. Neural Plast 2015: 581976. |
[10] |
Lima-Ojeda JM, Rupprecht R, Baghai TC (2018) Neurobiology of depression: A neurodevelopmental approach. World J Biol Psychiatry 19: 349-359. doi: 10.1080/15622975.2017.1289240
![]() |
[11] |
Vythilingam M, Heim C, Newport J, et al. (2002) Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 159: 2072-2080. doi: 10.1176/appi.ajp.159.12.2072
![]() |
[12] |
Aan Het Rot M, Mathews SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180: 305-313. doi: 10.1503/cmaj.080697
![]() |
[13] |
Ignácio ZM, Da Silva RS, Plissari ME, et al. (2019) Physical Exercise and Neuroinflammation in Major Depressive Disorder. Mol Neurobiol 56: 8323-8335. doi: 10.1007/s12035-019-01670-1
![]() |
[14] | Ignácio ZM, Réus GZ, Quevedo J, et al. (2017) Maternal Deprivation. Reference Module in Neuroscience and Biobehavioral Psychology. Elsevier Available from: https://doi.org/10.1016/B978-0-12-809324-5.00352-7. |
[15] | Saraceno B, Levav I, Kohn R (2005) The public mental health significance of research on socioeconomic factors in schizophrenia and major depression. World Psychiatry 4: 181-185. |
[16] |
Lorant V, Deliege D, Eaton W, et al. (2003) Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 157: 98-112. doi: 10.1093/aje/kwf182
![]() |
[17] |
Husain N, Creed F, Tomenson B (2002) Depression and social stress in Pakistan. Psychol Med 30: 395-402. doi: 10.1017/S0033291700001707
![]() |
[18] | Probst JC, Laditka S, Moore CG, et al. (2005) Depression in rural populations: Prevalence, effects on life quality and treatment-seeking behavior. South Carolina Rural Health Res Cent. 1-64. |
[19] |
Sidlauskaitė-Stripeikienė I, Zemaitienė N, Klumbienė J (2010) Associations between depressiveness and psychosocial factors in Lithuanian rural population. Medicina 46: 693-699. doi: 10.3390/medicina46100098
![]() |
[20] | (2010) SEBRAESanta Catarina em Números: Nova Erechim. Florianópolis: Sebrae/SC 113. |
[21] | Derogatis LR (1994) SCL-90-R: symptom checklist-90-R: administration, scoring & procedures manual Minneapolis: National Computer Systems, 123. |
[22] | Lipp MEN, Guevara AJH (1994) Validação empírica do Inventário de Sintomas de Stress. Estud de Psicologia 11: 43-49. |
[23] | Henna E, Zilberman ML (2016) Instrumentos de Avaliação de Aspectos Adicionais Relacionados à Saúde Mental. Instrumentos de Avaliação em Saúde Mental Porto Alegre: Editora Artmed, 432-435. |
[24] | Gorestein C, Andrade LHSG (1998) Inventário de depressão de Beck: propriedades psicométricas da versão em português. Rev de Psiquiatr Clín 25: 245-250. |
[25] |
Kominami G, Fujisaka I, Yamauchi A, et al. (1980) A sensitive enzime immunoassay for plasma cortisol. Clin Chim Acta 103: 381-391. doi: 10.1016/0009-8981(80)90158-8
![]() |
[26] |
Holder G (2006) Measurement of Glucocorticoids in Biological Fluids. Methods in Molecular Biology: Hormone Assays in Biological Fluids Totowa: Humana Press, 141-157. doi: 10.1385/1-59259-986-9:141
![]() |
[27] |
Richter P, Werner J, Heerlein A, et al. (1998) On the validity of the Beck Depression Inventory. A review. Psychopathology 31: 160-168. doi: 10.1159/000066239
![]() |
[28] | Tolahunase MR, Sagar R, Faiq M, et al. (2018) Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial. Restor Neurol Neurosci 36: 423-442. |
[29] |
Kazemi A, Noorbala AA, Azam K, et al. (2018) Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin Nutr 38: 522-528. doi: 10.1016/j.clnu.2018.04.010
![]() |
[30] |
DiNapoli EA, Pierpaoli CM, Shah A, et al. (2017) Effects of Home-Delivered Cognitive Behavioral Therapy (CBT) for Depression on Anxiety Symptoms among Rural, Ethnically Diverse Older Adults. Clin Gerontol 40: 181-190. doi: 10.1080/07317115.2017.1288670
![]() |
[31] |
Simpkin AL, Khan A, West DC, et al. (2018) Stress From Uncertainty and Resilience Among Depressed and Burned Out Residents: A Cross-Sectional Study. Acad Pediatr 18: 698-704. doi: 10.1016/j.acap.2018.03.002
![]() |
[32] |
Hill MN, Hellemans KG, Verma P, et al. (2012) Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 36: 2085-2117. doi: 10.1016/j.neubiorev.2012.07.001
![]() |
[33] |
Hodes GE, Kana V, Menard C, et al. (2015) Neuroimmune mechanisms of depression. Nat Neurosci 18: 1386-1393. doi: 10.1038/nn.4113
![]() |
[34] |
Dean J, Keshavan M (2017) The neurobiology of depression: An integrated view. Asian J Psychiatr 27: 101-111. doi: 10.1016/j.ajp.2017.01.025
![]() |
[35] |
Kennis M, Gerritsen L, Van Dalen M, et al. (2020) Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry 25: 321-338. doi: 10.1038/s41380-019-0585-z
![]() |
[36] |
Padgett DA, Glaser R (2003) How stress influences the immune response. Trends Immunol 24: 444-448. doi: 10.1016/S1471-4906(03)00173-X
![]() |
[37] |
Slavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull 140: 774-815. doi: 10.1037/a0035302
![]() |
[38] |
Jia Y, Liu L, Sheng C, et al. (2019) Increased Serum Levels of Cortisol and Inflammatory Cytokines in People With Depression. J Nerv Ment Dis 207: 271-276. doi: 10.1097/NMD.0000000000000957
![]() |
[39] |
Rohleder N (2012) Acute and chronic stress induced changes in sensitivity of peripheral inflammatory pathways to the signals of multiple stress systems—2011 Curt Richter award winner. Psychoneuroendocrinology 37: 307-316. doi: 10.1016/j.psyneuen.2011.12.015
![]() |
[40] |
Burke HM, Davis MC, Otte C, et al. (2005) Depression and cortisol responses to psychological stress: A meta-analysis. Psychoneuroendocrinology 30: 846-856. doi: 10.1016/j.psyneuen.2005.02.010
![]() |
[41] |
Fiksdal A, Hanlin L, Kuras Y, et al. (2019) Associations Between Symptoms of Depression and Anxiety and Cortisol Responses to and Recovery from Acute Stress. Psychoneuroendocrinology 102: 44-52. doi: 10.1016/j.psyneuen.2018.11.035
![]() |
[42] |
Chen L, Deng H, Cui H, et al. (2018) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9: 7204-7218. doi: 10.18632/oncotarget.23208
![]() |
[43] |
Chan KL, Cathomas F, Russo SJ (2019) Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder. Physiol Bethesda 34: 123-133. doi: 10.1152/physiol.00047.2018
![]() |
[44] |
Brydon L, Edwards S, Mohamed-Ali V, et al. (2004) Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav Immun 18: 281-290. doi: 10.1016/j.bbi.2003.09.011
![]() |
1. | Joanna Mikulska, Gabriela Juszczyk, Monika Gawrońska-Grzywacz, Mariola Herbet, HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation, 2021, 11, 2076-3425, 1298, 10.3390/brainsci11101298 | |
2. | Gabriel R. Fries, Valeria A. Saldana, Johannes Finnstein, Theo Rein, Molecular pathways of major depressive disorder converge on the synapse, 2023, 28, 1359-4184, 284, 10.1038/s41380-022-01806-1 | |
3. | Katharine Ann James, Juliet Ilena Stromin, Nina Steenkamp, Marc Irwin Combrinck, Understanding the relationships between physiological and psychosocial stress, cortisol and cognition, 2023, 14, 1664-2392, 10.3389/fendo.2023.1085950 | |
4. | Cailan Lindsay Feingold, Abbas Smiley, Healthy Sleep Every Day Keeps the Doctor Away, 2022, 19, 1660-4601, 10740, 10.3390/ijerph191710740 | |
5. | Kelly J. Heard, Maxim N. Shokhirev, Caroline Becronis, Callie Fredlender, Nadia Zahid, Amy T. Le, Yuan Ji, Michelle Skime, Timothy Nelson, Daniel Hall-Flavin, Richard Weinshilboum, Fred H. Gage, Krishna C. Vadodaria, Chronic cortisol differentially impacts stem cell-derived astrocytes from major depressive disorder patients, 2021, 11, 2158-3188, 10.1038/s41398-021-01733-9 | |
6. | ManojK Sahu, RajeshK Dubey, Alka Chandrakar, Mahesh Kumar, Mahendra Kumar, A systematic review and meta-analysis of serum and plasma cortisol levels in depressed patients versus control, 2022, 64, 0019-5545, 440, 10.4103/indianjpsychiatry.indianjpsychiatry_561_21 | |
7. | K. Gao, C.-L. Chen, X.-Q. Ke, Y.-X Yu, S. Chen, G.-C. Liu, H.-F. Wang, Y.-J. Li, Ingestion of Lactobacillus helveticus WHH1889 improves depressive and anxiety symptoms induced by chronic unpredictable mild stress in mice, 2022, 13, 1876-2883, 473, 10.3920/BM2022.0052 | |
8. | Talha Iqbal, Adnan Elahi, William Wijns, Atif Shahzad, Cortisol detection methods for stress monitoring in connected health, 2023, 6, 27726320, 100079, 10.1016/j.hsr.2023.100079 | |
9. | Jing Yung Lai, Jian Xiang Ho, Audrey Siew Foong Kow, Gengfan Liang, Chau Ling Tham, Yu-Cheng Ho, Ming Tatt Lee, Interferon therapy and its association with depressive disorders – A review, 2023, 14, 1664-3224, 10.3389/fimmu.2023.1048592 | |
10. | Yongbo Hu, Jin Li, Youjin Zhao, Zaiquan Dong, Peiyuan Qiu, Shujuan Yang, Haizhen Xu, Weihong Kuang, Qiyong Gong, Memory and processing speed impairments in first-episode drug-naïve patients with major depressive disorder, 2023, 322, 01650327, 99, 10.1016/j.jad.2022.10.048 | |
11. | Ifat Israel-Elgali, Libi Hertzberg, Guy Shapira, Aviv Segev, Israel Krieger, Uri Nitzan, Yuval Bloch, Nir Pillar, Ori Mayer, Abraham Weizman, David Gurwitz, Noam Shomron, Blood transcriptional response to treatment-resistant depression during electroconvulsive therapy, 2021, 141, 00223956, 92, 10.1016/j.jpsychires.2021.06.039 | |
12. | Silvia Vivarelli, Sebastiano Italia, Michele Teodoro, Manuela Pollicino, Carmen Vitello, Annalisa De Vita, Angela Alibrandi, Chiara Costa, Concettina Fenga, Salivary Biomarkers Analysis and Neurobehavioral Assessment in Nurses Working Rotation Shifts: A Pilot Study, 2023, 20, 1660-4601, 5376, 10.3390/ijerph20075376 | |
13. | David Antoine Lachmansingh, Aonghus Lavelle, John F. Cryan, Gerard Clarke, 2023, Chapter 449, 978-3-031-66355-0, 175, 10.1007/7854_2023_449 | |
14. | Saeed Vaheb, Yousef Mokary, Mohammad Yazdan Panah, Aysa Shaygannejad, Alireza Afshari-Safavi, Majid Ghasemi, Vahid Shaygannejad, Elham Moases Ghaffary, Omid Mirmosayyeb, Multiple sclerosis and personality traits: associations with depression and anxiety, 2024, 29, 2047-783X, 10.1186/s40001-024-01772-0 | |
15. | Xiaoting Yang, Mei Cai, New Insights into the Mutual Promotion of Rosacea, Anxiety, and Depression from Neuroendocrine Immune Aspects, 2023, Volume 16, 1178-7015, 1363, 10.2147/CCID.S413237 | |
16. | Hongwei Kong, Tianren Xu, Shengguang Wang, Zhiyuan Zhang, Min Li, Suyan Qu, Qinqing Li, Peng Gao, Zhufeng Cong, The molecular mechanism of polysaccharides in combating major depressive disorder: A comprehensive review, 2024, 259, 01418130, 129067, 10.1016/j.ijbiomac.2023.129067 | |
17. | Yaxin Zhang, Anyuyang Fan, Juan Du, Xuemei Shi, Shiyu Yang, Na Gao, Lili Pan, Taotao Li, Risk factors and prognosis of depression in Takayasu arteritis patients, 2024, 16, 1759-720X, 10.1177/1759720X241296414 | |
18. | Julia N. Khantakova, Anastasia Mutovina, Kseniya A. Ayriyants, Natalia P. Bondar, Th17 Cells, Glucocorticoid Resistance, and Depression, 2023, 12, 2073-4409, 2749, 10.3390/cells12232749 | |
19. | Anna Rosa van der Heijden, Tom Houben, Lipids in major depressive disorder: new kids on the block or old friends revisited?, 2023, 14, 1664-0640, 10.3389/fpsyt.2023.1213011 | |
20. | Xu-Yi Li, Shi-Ya Zhang, Yi-Zhou Hong, Zhi-Gang Chen, Yan Long, Dan-Hua Yuan, Jia-Jia Zhao, Su-Su Tang, Hao Wang, Hao Hong, TGR5-mediated lateral hypothalamus-dCA3-dorsolateral septum circuit regulates depressive-like behavior in male mice, 2024, 112, 08966273, 1795, 10.1016/j.neuron.2024.02.019 | |
21. | Matylda Buczkowska, Eleonora Iob, Testing the causal relationship of fat and sugar intake with depression and cortisol: a Mendelian Randomisation study, 2024, 14, 2158-3188, 10.1038/s41398-024-03089-2 | |
22. | Menglin Liu, Genhao Fan, Lingkai Meng, Kuo Yang, Huayi Liu, New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside, 2024, 1673-1581, 10.1631/jzus.B2300343 | |
23. | Masoomeh Dadkhah, Mohsen Jafarzadehgharehziaaddin, Soheila Molaei, Morteza Akbari, Negin Gholizadeh, Farzaneh Fathi, Major depressive disorder: Biomarkers and biosensors, 2023, 547, 00098981, 117437, 10.1016/j.cca.2023.117437 | |
24. | Gislaine Z. Réus, Kelen C. C. Recco, Karynne M. S. H. Machado, Ritele H. Silva, Camila O. Arent, Graziela Amboni, Flávia S. Niero, Lucas C. Pedro, Laura A. Borba, Margarete D. Bagatini, Gabriela G. de Oliveira, Alana Patrícia da Silva, Maiqueli Eduarda D. Mingoti, Zuleide Maria Ignácio, Fernanda F. Gava, Fabricia Petronilho, João Quevedo, Luciane B. Ceretta, Taiane de Azevedo Cardoso, COVID-19, Anxiety, and Body Mass Index Increase Leptin Levels: a Cross-sectional Multicentric Study, 2023, 0893-7648, 10.1007/s12035-023-03788-9 | |
25. | Penelope C. Farris, Sean T. Lynch, Emily Groenendaal, Lidia Klepacz, LCSW Bambina Meyers, Stephen J. Ferrando, Impact of progressive muscle relaxation on psychological symptoms on an inpatient psychiatric unit, 2023, 4, 29498341, 100033, 10.1016/j.bbii.2023.100033 | |
26. | Yezan Hassan, Sara C. Esteves, Jonna M. Leyrer-Jackson, Mark P. Thomas, 2024, Chapter 56, 978-3-031-68236-0, 1025, 10.1007/978-3-031-68237-7_56 | |
27. | Brenda Carolina Mattia-Maximiano, Mariana Mioranza-Koppe, Ritele H. Silva, Camila O. Arent, Graziela Amboni, Lucas C. Pedro, Amanda Gollo Bertollo, Arthur Dellazeri Cortez, Jesiel de Medeiros, Fernanda Pedrotti Moreira, João Quevedo, Luciane B. Ceretta, Zuleide Maria Ignácio, Taiane de Azevedo Cardoso, Gislaine Zilli Réus, Biological rhythms and psychiatric symptoms in COVID-19 individuals: a cross-sectional multicentric study, 2025, 0929-1016, 1, 10.1080/09291016.2024.2449337 | |
28. | Rodrigo Sudatti Delevatti, Larissa Leonel, Felipe Barreto Schuch, Elisa Côrrea Marson, Salime Donida Chedid Lisboa, Thais Reichert, Ana Carolina Kanitz, Vitória de Mello Bone, Luiz Fernando Martins Kruel, Aquatic training and sleep quality, depressive symptoms and quality of life in patients with type 2 diabetes: Diabetes and Aquatic Training Study (DATS2)- A Randomized Controlled Trial, 2025, 17552966, 100670, 10.1016/j.mhpa.2025.100670 | |
29. | Darko Kastelan, Tina Dusek, Do adrenal incidentalomas have an impact on mental health? A comprehensive review, 2025, 192, 0804-4643, R1, 10.1093/ejendo/lvaf011 |
Group | Average years age | Gender | School Education Level |
||||
Incomplete Elementary | Complete Elementary | Incomplete high | Complete high | University Education | |||
Control | 48 | F = 17 M = 0 |
8 | 2 | 0 | 4 | 3 |
MDD | 53 | F = 15 M = 2 |
6 | 6 | 0 | 3 | 2 |